Cargando…
Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?
Prediction of benefit from combined chemotherapy and the antiepidermal growth factor receptor cetuximab is a not yet solved question in head and neck squamous cell carcinoma (HNSCC). In a selected series of 14 long progression-free survival (PFS) and 26 short PFS patients by whole gene and microRNA...
Autores principales: | Bossi, Paolo, Siano, Marco, Bergamini, Cristiana, Cossu Rocca, Maria, Sponghini, Andrea P., Giannoccaro, Marco, Tonella, Luca, Paoli, Alessandro, Marchesi, Edoardo, Perrone, Federica, Pilotti, Silvana, Locati, Laura D., Canevari, Silvana, Licitra, Lisa, De Cecco, Loris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702394/ https://www.ncbi.nlm.nih.gov/pubmed/29259349 http://dx.doi.org/10.1155/2017/6870614 |
Ejemplares similares
-
Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer
por: De Cecco, Loris, et al.
Publicado: (2017) -
Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data
por: De Cecco, Loris, et al.
Publicado: (2015) -
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma
por: Bossi, Paolo, et al.
Publicado: (2016) -
Mining of Self-Organizing Map Gene-Expression Portraits Reveals Prognostic Stratification of HPV-Positive Head and Neck Squamous Cell Carcinoma
por: Locati, Laura D., et al.
Publicado: (2019) -
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report
por: Locati, Laura Deborah, et al.
Publicado: (2022)